Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

KinDex Pharmaceuticals Inc.

www.kindexpharmaceuticals.com

Latest From KinDex Pharmaceuticals Inc.

Series A Rounds H1 2014: Fewer Deals, Comparable Money

The money raised in Series A financings for biopharma, medtech, and diagnostics start-ups is down 8% from the same period last year, but the number of deals is down even more dramatically.

Medical Device BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
  • Pharmaceuticals
  • Therapeutic Areas
  • Inflammation
  • Metabolic Disorders
  • Alias(es)
  • KinDex Therapeutics LLC
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • KinDex Pharmaceuticals Inc.
  • Senior Management
  • Jeffrey Bland, Pres. & CEO
    Lincoln Bouillon, CFO
    Neile Grayson, VP, Drug Dev.
  • Contact Info
  • KinDex Pharmaceuticals Inc.
    Phone: (206) 922-2912
    800 Fifth Ave., Ste. 4100
    Seattle, WA 98104
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register